Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease

24Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Non-alcoholic fatty liver disease (NAFLD), as one of the main causes of chronic liver disease worldwide, encompasses a spectrum of liver conditions that are not caused by other etiology, such as overt alcohol consumption, from simple steatosis to more aggressive non-alcoholic steatohepatitis (NASH) that involves liver inflammation and fibrosis, and to the lethal cirrhosis that may result in liver cancer and liver failure. The molecular mechanisms governing the transition from steatosis to NASH remain not fully understood, but the hepatic lipidome is extensively altered in the setting of steatosis and steatohepatitis, which also correlate with disease progression. With the tremendous advancement in the field of lipidomics in last two decades, a better understanding of the specific role of sphingolipids in fatty liver disease has taken shape. Among the numerous lipid subtypes that accumulate, ceramides are particularly impactful. On the one hand, excessive ceramides deposition in the liver cause hepatic steatosis. On the other hand, ceramides as lipotoxic lipid have significant effects on hepatic inflammation, apoptosis and insulin resistance that contribute to NAFLD. In this review, we summarize and evaluate current understanding of the multiple roles of ceramides in the onset of fatty liver disease and the pathogenic mechanisms underlying their effects, and we also discuss recent advances and challenges in pharmacological interventions targeting ceramide metabolism for the treatment of NAFLD.

References Powered by Scopus

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

1986Citations
N/AReaders
Get full text

Non-alcoholic fatty liver disease – A global public health perspective

1590Citations
N/AReaders
Get full text

Mechanisms and disease consequences of nonalcoholic fatty liver disease

1112Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis

17Citations
N/AReaders
Get full text

From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria

13Citations
N/AReaders
Get full text

Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicals

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Zhu, C., Huai, Q., Zhang, X., Dai, H., Li, X., & Wang, H. (2023). Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease. International Journal of Biological Sciences. Ivyspring International Publisher. https://doi.org/10.7150/ijbs.78525

Readers over time

‘23‘24‘250481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

40%

Researcher 4

40%

Professor / Associate Prof. 2

20%

Readers' Discipline

Tooltip

Nursing and Health Professions 3

30%

Biochemistry, Genetics and Molecular Bi... 3

30%

Agricultural and Biological Sciences 2

20%

Medicine and Dentistry 2

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1
References: 1

Save time finding and organizing research with Mendeley

Sign up for free
0